Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;89(1):53-60.
doi: 10.1007/s11126-017-9514-y.

Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia

Huiqiong Deng  1   2 , Ramandeep S Kahlon  3 , Satyajit Mohite  1   2 , Pooja A Amin  1 , Giovana Zunta-Soares  2 , Gabriela D Colpo  2 , Laura Stertz  2 , Gabriel R Fries  2 , Consuelo Walss-Bass  2 , Jair C Soares  1   2 , Olaoluwa O Okusaga  4   5
Affiliations

Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia

Huiqiong Deng et al. Psychiatr Q. 2018 Mar.

Abstract

S100B is a calcium binding protein mainly produced by glial cells. Previous studies have shown elevated levels of S100B in patients with schizophrenia. We measured S100B levels in fasting plasma of 39 patients with schizophrenia and 19 adult healthy controls. We used linear regression to compare S100B between patients and controls. In patients only, we also investigated the relationship between S100B levels and psychotic symptoms (assessed by the Positive and Negative Syndrome Scale), and cognitive function (assessed by the NIH Toolbox Cognition Battery), respectively by calculating Pearson's correlation coefficients. Mean plasma S100B was significantly higher in the patient group than in the control group. There were no significant correlations between plasma S100B and psychotic symptoms or cognition.

Keywords: Cognition; NIH toolbox cognition battery; Psychotic symptoms; S100B; Schizophrenia.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Psychiatr Res. 2007 Jan-Feb;41(1-2):36-42 - PubMed
    1. J Psychiatr Res. 2010 Dec;44(16):1236-40 - PubMed
    1. Neurosci Lett. 2009 Sep 22;462(2):113-7 - PubMed
    1. Iran J Pharm Res. 2016 Winter;15(1):323-30 - PubMed
    1. J Psychiatr Res. 2001 Jan-Feb;35(1):11-4 - PubMed

Substances

LinkOut - more resources